Del Casale A et al. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Current Neuropharmacology. August 2019. Obsessive-Compulsive Disorder (OCD). Mayo Clinic. December 21, 2023.

When COVID arrived early in 2020, pandemic restrictions made in-person mental health care difficult or impossible. Both ...

Del Casale A et al. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Current Neuropharmacology. August 2019. Obsessive-Compulsive Disorder (OCD). Mayo Clinic. December 21, 2023.

Obsessive-compulsive disorder currently affects 2.5% of the United States population and can be treated with what is called exposure and response prevention therapy, or ERPT.

Obsessive-compulsive disorder currently affects 2.5% of the United States population and can be treated with what is called exposure and response prevention therapy, or ERPT.